{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T13:10:32Z","timestamp":1742217032397,"version":"3.38.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s40615-024-01968-4","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T21:22:01Z","timestamp":1710278521000},"page":"1344-1356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disparities in Social Vulnerability and Premature Mortality among Decedents with Hepatitis B, United States, 2010\u20132019"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4331-1389","authenticated-orcid":false,"given":"Kathleen N.","family":"Ly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2633-6640","authenticated-orcid":false,"given":"Shaoman","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7609-0485","authenticated-orcid":false,"given":"Philip R.","family":"Spradling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"1968_CR1","unstructured":"US Department of Health and Human Services. 2020. Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021\u20132025). Washington, DC."},{"key":"1968_CR2","unstructured":"Centers for Disease Control and Prevention. Viral hepatitis surveillance\u2013United States. Available at https:\/\/www.cdc.gov\/hepatitis\/statistics\/SurveillanceRpts.htm. Accessed on March 27, 2023."},{"issue":"6","key":"1968_CR3","doi-asserted-by":"publisher","first-page":"e2219170","DOI":"10.1001\/jamanetworkopen.2022.19170","volume":"5","author":"KN Ly","year":"2022","unstructured":"Ly KN, Yin S, Spradling PR. Regional differences in mortality rates and characteristics of decedents with hepatitis B listed as a cause of death, United States, 2000\u20132019. JAMA Netw Open. 2022;5(6):e2219170.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1968_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.15585\/mmwr.mm6503a2","volume":"65","author":"AM Harris","year":"2016","unstructured":"Harris AM, Iqbal K, Schillie S, Britton J, Kainer MA, Tressler S, Vellozzi C. Increases in acute hepatitis B virus infections - Kentucky, Tennessee, and West Virginia, 2006\u20132013. MMWR Morb Mortal Wkly Rep. 2016;65(3):47\u201350.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"1968_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","volume":"72","author":"EE Conners","year":"2023","unstructured":"Conners EE, Panagiotakopoulos L, Hofmeister MG, et al. Screening and testing for hepatitis B virus infection: CDC recommendations \u2014 United States, 2023. MMWR Recommendations and Reports. 2023;72(1):1\u201325.","journal-title":"MMWR Recommendations and Reports"},{"issue":"13","key":"1968_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.15585\/mmwr.mm7113a1","volume":"71","author":"MK Weng","year":"2022","unstructured":"Weng MK, Doshani M, Khan MA, et al. Universal hepatitis B vaccination in adults aged 19\u201359 years: updated recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022. MMWR Weekly. 2022;71(13):477\u201383.","journal-title":"MMWR Weekly"},{"issue":"4","key":"1968_CR7","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","volume":"67","author":"NA Terrault","year":"2018","unstructured":"Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560\u201399.","journal-title":"Hepatology"},{"issue":"2","key":"1968_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398.","journal-title":"J Hepatol"},{"issue":"5","key":"1968_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.cgh.2013.09.062","volume":"12","author":"SC Gordon","year":"2014","unstructured":"Gordon SC, Lamerato LE, Rupp LB, et al. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population. Clin Gastroenterol Hepatol. 2014;12(5):885\u201393.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1968_CR10","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/hep.31554","volume":"73","author":"AS Lok","year":"2021","unstructured":"Lok AS, Perrillo R, Lalama CM, et al. Low incidence of adverse outcomes in adults with chronic hepatitis B virus infection in the era of antiviral therapy. Hepatology. 2021;73(6):2124\u201340.","journal-title":"Hepatology"},{"issue":"5","key":"1968_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/jvh.13060","volume":"26","author":"HS Kim","year":"2019","unstructured":"Kim HS, Yang JD, El-Serag HB, Kanwal F. Awareness of chronic viral hepatitis in the United States: an update from the National Health and Nutrition Examination Survey. J Viral Hepat. 2019;26(5):596\u2013602.","journal-title":"J Viral Hepat"},{"key":"1968_CR12","unstructured":"US Department of Health and Human Services. Healthy People 2030: Social determinants of health literature summaries. Available at https:\/\/health.gov\/healthypeople\/priority-areas\/social-determinants-health\/literature-summaries#block-sdohinfographics. Accessed on June 13, 2023."},{"key":"1968_CR13","unstructured":"CDC Agency for Toxic Substances and Disease Registry. CDC\/ATSDR Social vulnerability index. Available at https:\/\/www.atsdr.cdc.gov\/placeandhealth\/svi\/index.html. Accessed on January 13, 2023."},{"key":"1968_CR14","doi-asserted-by":"publisher","unstructured":"Bevan G, Pandey A, Griggs S, Dalton JE, Zidar D, Patel S, et al. Neighborhood-level social vulnerability and prevalence of cardiovascular risk factors and coronary heart disease. Curr Probl Cardiol. 2023;48(8):101182. https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101182.","DOI":"10.1016\/j.cpcardiol.2022.101182"},{"issue":"3","key":"1968_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jaccao.2022.06.005","volume":"4","author":"S Ganatra","year":"2022","unstructured":"Ganatra S, Dani SS, Kumar A, et al. Impact of social vulnerability on comorbid cancer and cardiovascular disease mortality in the United States. JACC CardioOncol. 2022;4(3):326\u201337.","journal-title":"JACC CardioOncol"},{"issue":"2","key":"1968_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2023.100086","volume":"2","author":"RW Knoebel","year":"2023","unstructured":"Knoebel RW, Kim SJ. Impact of COVID-19 pandemic, social vulnerability, and opioid overdoses in Chicago. AJPM Focus. 2023;2(2): 100086.","journal-title":"AJPM Focus"},{"issue":"11","key":"1968_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1097\/INF.0000000000003689","volume":"41","author":"LD Zambrano","year":"2022","unstructured":"Zambrano LD, Ly KN, Link-Gelles R, et al. Investigating health disparities associated with multisystem inflammatory syndrome in children after SARS-CoV-2 infection. Pediatr Infect Dis J. 2022;41(11):891\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"1968_CR18","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.2105\/AJPH.2022.307018","volume":"112","author":"R Tipirneni","year":"2022","unstructured":"Tipirneni R, Schmidt H, Lantz PM, Karmakar M. Associations of 4 geographic social vulnerability indices with US COVID-19 incidence and mortality. Am J Public Health. 2022;112(11):1584\u20138.","journal-title":"Am J Public Health"},{"key":"1968_CR19","unstructured":"CDC National Centers for Health Statistics. Restricted-use vital statistics data. Available at https:\/\/www.cdc.gov\/nchs\/nvss\/nvss-restricted-data.htm. Accessed on January 13, 2023."},{"key":"1968_CR20","unstructured":"Organization. WH. International Statistical Classification of Diseases, Tenth Revision (ICD-10). World Health Organization; 1992."},{"key":"1968_CR21","unstructured":"Centers for Disease Control and Prevention. US standard certificate of death. Available at https:\/\/www.cdc.gov\/nchs\/data\/dvs\/death11-03final-acc.pdf. Accessed on February 20, 2024."},{"issue":"7","key":"1968_CR22","first-page":"1","volume":"63","author":"E Arias","year":"2014","unstructured":"Arias E. United States life tables, 2010. Natl Vital Stat Rep. 2014;63(7):1\u201363.","journal-title":"Natl Vital Stat Rep"},{"issue":"11","key":"1968_CR23","first-page":"1","volume":"64","author":"E Arias","year":"2015","unstructured":"Arias E. United States Life Tables, 2011. Natl Vital Stat Rep. 2015;64(11):1\u201363.","journal-title":"Natl Vital Stat Rep"},{"issue":"8","key":"1968_CR24","first-page":"1","volume":"65","author":"E Arias","year":"2016","unstructured":"Arias E, Heron M, Xu J. United States Life Tables, 2012. Natl Vital Stat Rep. 2016;65(8):1\u201365.","journal-title":"Natl Vital Stat Rep"},{"issue":"3","key":"1968_CR25","first-page":"1","volume":"66","author":"E Arias","year":"2017","unstructured":"Arias E, Heron M, Xu J. United States Life Tables, 2013. Natl Vital Stat Rep. 2017;66(3):1\u201364.","journal-title":"Natl Vital Stat Rep"},{"issue":"4","key":"1968_CR26","first-page":"1","volume":"66","author":"E Arias","year":"2017","unstructured":"Arias E, Heron M, Xu J. United States Life Tables, 2014. Natl Vital Stat Rep. 2017;66(4):1\u201364.","journal-title":"Natl Vital Stat Rep"},{"issue":"7","key":"1968_CR27","first-page":"1","volume":"67","author":"E Arias","year":"2018","unstructured":"Arias E, Xu J. United States Life Tables, 2015. Natl Vital Stat Rep. 2018;67(7):1\u201364.","journal-title":"Natl Vital Stat Rep"},{"issue":"4","key":"1968_CR28","first-page":"1","volume":"68","author":"E Arias","year":"2019","unstructured":"Arias E, Xu J, Kochanek KD. United States Life Tables, 2016. Natl Vital Stat Rep. 2019;68(4):1\u201366.","journal-title":"Natl Vital Stat Rep"},{"issue":"7","key":"1968_CR29","first-page":"1","volume":"68","author":"E Arias","year":"2019","unstructured":"Arias E. United States Life Tables, 2017. Natl Vital Stat Rep. 2019;68(7):1\u201366.","journal-title":"Natl Vital Stat Rep"},{"issue":"12","key":"1968_CR30","first-page":"1","volume":"69","author":"E Arias","year":"2020","unstructured":"Arias E, Xu J. United States Life Tables, 2018. Natl Vital Stat Rep. 2020;69(12):1\u201345.","journal-title":"Natl Vital Stat Rep"},{"issue":"19","key":"1968_CR31","first-page":"1","volume":"70","author":"E Arias","year":"2022","unstructured":"Arias E, Xu J. United States Life Tables, 2019. Natl Vital Stat Rep. 2022;70(19):1\u201359.","journal-title":"Natl Vital Stat Rep"},{"key":"1968_CR32","unstructured":"Centers for Disease Control and Prevention. Principles of Epidemiology. Lesson 3: measures of risk. Available at https:\/\/www.cdc.gov\/csels\/dsepd\/ss1978\/lesson3\/section3.html. Accessed on July 24, 2023."},{"key":"1968_CR33","unstructured":"Centers for Disease Control and Prevention. CDC WONDER Multiple Cause of Death 1999\u20132020 Dataset Documentation. Available at https:\/\/wonder.cdc.gov\/wonder\/help\/mcd.html#. Accessed on June 13, 2023."},{"issue":"1","key":"1968_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cgh.2014.06.028","volume":"13","author":"MG Ghany","year":"2015","unstructured":"Ghany MG, Perrillo R, Li R, et al. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015;13(1):183\u201392.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1968_CR35","first-page":"32","volume":"28","author":"KL Schmid","year":"2008","unstructured":"Schmid KL, Rivers SE, Latimer AE, Salovey P. Targeting or tailoring? Mark Health Serv. 2008;28(1):32\u20137.","journal-title":"Mark Health Serv"},{"issue":"5 Suppl","key":"1968_CR36","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1002\/hep.22882","volume":"49","author":"CM Weinbaum","year":"2009","unstructured":"Weinbaum CM, Mast EE, Ward JW. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. Hepatology. 2009;49(5 Suppl):S35-44.","journal-title":"Hepatology"},{"issue":"4","key":"1968_CR37","doi-asserted-by":"publisher","first-page":"e237018","DOI":"10.1001\/jamanetworkopen.2023.7018","volume":"6","author":"M Khalili","year":"2023","unstructured":"Khalili M, Leonard KR, Ghany MG, et al. Racial disparities in treatment initiation and outcomes of chronic hepatitis B virus infection in North America. JAMA Netw Open. 2023;6(4):e237018.","journal-title":"JAMA Netw Open"},{"key":"1968_CR38","unstructured":"Centers for Disease Control and Prevention. 2020 Viral hepatitis surveillance report. Available at https:\/\/www.cdc.gov\/hepatitis\/statistics\/2020surveillance\/index.htm. Accessed on June 16, 2023."},{"key":"1968_CR39","unstructured":"Centers for Disease Control and Prevention. Drug overdose death rate maps & graphs. Available at https:\/\/www.cdc.gov\/drugoverdose\/deaths\/index.html. Accessed on June 16, 2023."},{"issue":"6","key":"1968_CR40","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1093\/cid\/ciy598","volume":"68","author":"D Bixler","year":"2019","unstructured":"Bixler D, Zhong Y, Ly KN, et al. Mortality among patients with chronic hepatitis B infection: The Chronic Hepatitis Cohort Study (CHeCS). Clin Infect Dis. 2019;68(6):956\u201363.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"1968_CR41","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/hepr.12437","volume":"45","author":"KN Ly","year":"2015","unstructured":"Ly KN, Speers S, Klevens RM, Barry V, Vogt TM. Measuring chronic liver disease mortality using an expanded cause of death definition and medical records in Connecticut, 2004. Hepatol Res. 2015;45(9):960\u20138.","journal-title":"Hepatol Res"},{"issue":"4","key":"1968_CR42","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/hep.22181","volume":"47","author":"MM Manos","year":"2008","unstructured":"Manos MM, Leyden WA, Murphy RC, Terrault NA, Bell BP. Limitations of conventionally derived chronic liver disease mortality rates: results of a comprehensive assessment. Hepatology. 2008;47(4):1150\u20137.","journal-title":"Hepatology"},{"key":"1968_CR43","first-page":"1","volume":"148","author":"E Arias","year":"2008","unstructured":"Arias E, Schauman WS, Eschbach K, Sorlie PD, Backlund E. The validity of race and Hispanic origin reporting on death certificates in the United States. Vital Health Stat 2. 2008;148:1\u201323.","journal-title":"Vital Health Stat 2"},{"key":"1968_CR44","unstructured":"Centers for Disease Control and Prevention. Public use data file documentation mortality multiple cause-of-death. Avalable at https:\/\/www.cdc.gov\/nchs\/nvss\/mortality_public_use_data.htm. Accessed on June 26, 2023."},{"issue":"5","key":"1968_CR45","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/jnci\/djad047","volume":"115","author":"YT Shih","year":"2023","unstructured":"Shih YT, Bradley C, Yabroff KR. Ecological and individualistic fallacies in health disparities research. J Natl Cancer Inst. 2023;115(5):488\u201391.","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-024-01968-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-024-01968-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-024-01968-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T12:31:15Z","timestamp":1742214675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-024-01968-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1968"],"URL":"https:\/\/doi.org\/10.1007\/s40615-024-01968-4","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"type":"print","value":"2197-3792"},{"type":"electronic","value":"2196-8837"}],"subject":[],"published":{"date-parts":[[2024,3,12]]},"assertion":[{"value":"6 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This analysis did not require institutional review board review per HHS Code of Federal Regulations Title 45 Part 46 2018 because de-identified data were obtained for decedents from secondary sources.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This study was deemed exempt from institutional review board review and informed consent per HHS Code of Federal Regulations Title 45 Part 46 2018 because all data were obtained from secondary sources without personally identifiable information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"This study was deemed exempt from institutional review board review and informed consent per HHS Code of Federal Regulations Title 45 Part 46 2018 because all data were obtained from secondary sources without personally identifiable information.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The findings and conclusions in this report do not necessarily reflect the official position of the Centers for Disease Control and Prevention.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"CDC Disclaimer"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}